Silo Pharma, Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. We are committed to developing innovative solutions to address a variety of underserved conditions.

Silo Pharma Inc’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry. In these uncertain times, the mental health of the nation and beyond is being put to the test. More than ever, creative new therapies and lines of thought are needed to address health challenges of today. Combining our resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Recent News

Get the atai
Investor’s Kit now.


Market Cap